Detection of Single Nucleotide Polymorphism (SNP) (rs34819629) and its Association with Pediatric Type 1 Diabetes Mellitus

Document Type : Original Article

Authors

1 Pediatric department, Faculty of Medicine, Beni-Suef University, Egypt

2 Clinical and chemical pathology department, Faculty of Medicine, Beni-Suef University, Egypt.

Abstract

Background: Diabetes mellitus (DM) is a chronic metabolic disorder caused by an absolute or relative deficiency of insulin, an anabolic hormone. Insulin is produced by the beta cells of the islets of Langerhans located in the pancreas, and the absence, destruction, or other loss of these cells results in type 1 diabetes, so we aim to investigate the presence of a genetic association between single nucleotide polymorphism (SNP) and pediatric T1DM in a group of pediatric Egyptian patients. Patient and method: The study was a case control study conducted on 80 diabetic subjects aged 5-15 years recruited from the endocrine clinic Pediatrics, Beni-Suef University, and 76 apparently healthy controls with matched age and sex.
All subjects were subjected to history taking, full clinical examination, laboratory tests (hemoglobin A1C, TSH, free T4, serum high density lipoprotein, serum low density lipoprotein, serum triglycerides) and SNP (rs34819629) was done by allelic discrimination technique using real time PCR. Results:  In our study, the diabetic patients were 28 males (35.0%) and 52 females (65.0%), with a mean age of 10.0 ± 3.2 SD.AS for the control group they were 52 females (68.4%) and 24 males (31.6%) with a mean age 8.8 ± 2.8 SD and we found that Female cases affected more than males and No association was found in SNP (rs34819629) with Type 1 diabetes mellitus.Conclusion: Microalbuminuria was the most complication in our results and no association was found between SNP (rs34819629) and Type 1diabetes mellitus.

Keywords

Main Subjects

References

  1. Tian J, Liu Y, Chen K and Lyu S, (2017): “Cellular and molecular mechanisms of diabetic atherosclerosis: herbal medicines as a potential therapeutic approach,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 9080869, 16 pages.
  2. Lissauer and Carroll, (2017): The Science of Pediatrics – MRCPCH   Mastercourse; Chapter 26 page 500~502.
  3. Hensel K. O., Grimmer F., Roskopf M., Jenke A. C., Wirth S & Heusch A. (2016). Subclinical alterations of cardiac mechanics present early in the course of pediatric type 1 diabetes mellitus: a prospective blinded speckle tracking stress echocardiography study. Journal of diabetes research.‏
  4. Rechenberg K., Whittemore R., Grey M., Jaser S & TeenCOPE Research Group. (2016). Contribution of income to self‐management and health outcomes in pediatric type 1 diabetes. Pediatric diabetes, 17(2), 120-126.‏
  5. Steinbeck K. S., Shrewsbury V. A., Harvey V., Mikler K., Donaghue K. C., Craig M. E & Woodhead  H. J. (2015). A pilot randomized controlled trial of a post‐discharge program to support emerging adults with type 1 diabetes mellitus transition from pediatric to adult care. Pediatric Diabetes, 16(8), 634-639.‏
  6. Borschuk A. P & Everhart R. S. (2015). Health disparities among youth with type 1 diabetes: A systematic review of the current literature. Families, Systems, & Health, 33(3), 297.‏
  7. Sherr J. L., Hermann J. M., Campbell F., Foster N. C., Hofer S. E., Allgrove J., ... & Holl R. W. (2016). Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia, 59(1), 87-91.‏
  8. American Diabetes Association. 2 (2019). Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care, 42(Supplement 1), S13-S28.‏
  9. Katsarou A., Gudbjörnsdottir S., Rawshani A., Dabelea D., Bonifacio  E., Anderson  B. J., ... & Lernmark  Å. (2017). Type 1 diabetes mellitus. Nature reviews Disease primers, 3, 17016.‏
  10. Tornese G. (2016). Role of TRAIL (TNF-Related Apoptosis-Inducing Ligand) in the onset and progression of type 1 diabetes mellitus.
  11. Allard-Chamard H., Mishra H. K., Nandi M., Mayhue M., Menendez A., Ilangumaran S., & Ramanathan S. (2020). Interleukin-15 in autoimmunity. Cytokine, 136, 155258.
  12. El-Ziny MA, Salem NA,  El-Hawary AK, Chalaby NM, and  ElsharkawyAA (2014): Epidemiology of Childhood Type 1 Diabetes Mellitus in Nile Delta, Northern Egypt - A Retrospective Study. J Clin Res Pediatr Endocrinol. Vol; 6(1): pp9–15.
  13. Kadiki OA and Roaeid RB (2002): Incidence of type 1 diabetes in children (0-14 years) in Benghazi Libya (1991-2000) Diabetes Metab. Vol;28: pp463–467.
  14. Abduljabbar MA, Aljubeh JM, Amalraj A and Cherian MP (2010): Incidence trends of Childhood type 1 diabetes in eastern Saudi Arabia. Saudi Med J. Vol;31: pp413–418.
  15. Demirbilek H, Ozbek MN and Baran RT (2013): Incidence of type 1 diabetes mellitus in Turkish children from the southeastern region of the country: a regional report. J Clin Res Pediatr Endocrinol. Vol;5: pp98–103.
  16. Elamin A, Omer MI, Zein K and Tuvemo T (1992): Epidemiology of childhood type I diabetes in Sudan, 1987-1990. Diabetes Care. Vol;15: pp1556–1559.
  17. Shaltout AA, Moussa MA, Qabazard M, Abdella N, Karvonen M, Al Khawari M, Al-Arouj M, Al-Nakhi A, Tuomilehto J and El Gammal A (2002): Kuwait Diabetes Study Group. Further evidence for the rising incidence of childhood Type 1 diabetes in Kuwait. Diabet Med. Vol; 19: pp522–525.
  18. Ben Khalifa F, Mekaouar A, Taktak S, Hamhoum M, Jebara H, Kodia A, Zouari B and Chakroun M (1997): A five-year study of the incidence of insulin-dependent diabetes mellitus in young Tunisians (preliminary results) Diabetes Metab. Vol;23: pp395–401. 
  19. Schultz C. J., Konopelska-Bahu T., Dalton R. N., Carroll T. A., Stratton I., Gale E. A., ... & Dunger D. B. (1999). Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes care, 22(3), 495-502.
  20. Gallego P. H., Bulsara M. K., Frazer F., Lafferty A. R., Davis E. A., & Jones T. W. (2006). Prevalence and risk factors for microalbuminuria in a population‐based sample of children and adolescents with T1DM in Western Australia. Pediatric diabetes, 7(3), 165-172.
  21. Svensson M., Nyström L., Schön S., & Dahlquist G. (2006). Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes care, 29(3), 538-542.
  22. Qian C., Guo H., Chen X., Shi A., Li S., Wang X., ... & Fang C. (2018). Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility. Journal of diabetes research,
  23. Hameed M. Olla E. Khudhair, Jasim and Ibrahim A. Ahmed. (2020). Relation between genetic polymorphisms of PD-1 and susptibility to T1DM, College of Biotechnology/Al-Nahrain University, IRAQI.
  24. Ni R., Ihara K., Miyako K., Kuromaru R., Inuo M., Kohno H & Hara T.

Egyptian Journal of Medical Research
Volume 3, Issue 2
April 2022
Pages 185-195

Files

Share

How to cite

Statistics